CeriBell (CBLL) vs Enovis (ENOV)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 8, 2026.
Summary
CeriBell (CBLL) has outperformed Enovis (ENOV) over the past year, gaining 99.0% versus a loss of 41.9%. Enovis is the larger company by market cap ($1.01 billion vs $868.3 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CBLL | ENOV |
|---|---|---|
| Share price | $22.63 | $17.52 |
| Market cap | $868.30M | $1.01B |
| 1-day change | -3.64% | -0.51% |
| YTD return | +7.07% | -33.90% |
| 1-year return | +98.98% | -41.94% |
| 5-year return | — | -79.79% |
| Forward P/E | — | 4.88 |
| EPS (TTM) | $-1.76 | $-19.23 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $25.63 | $34.28 |
| 52-week low | $10.85 | $17.30 |
| Distance from 52-week high | -11.71% | -48.89% |
| Analyst consensus | strong_buy | strong_buy |
| Avg. price target upside | +26.28% | +114.50% |
| Average volume | 368.86K | 1.45M |
| Shares outstanding | 38.38M | 57.67M |
| Employees | 327 | 7,802 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Electromedical & Electrotherapeutic Apparatus | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- CBLL has outperformed ENOV by 140.9 percentage points over the past year.
About CeriBell
CBLL stock →CeriBell, Inc. operates as a medical technology company in the United States.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 327 employees
About Enovis
ENOV stock →Enovis Corporation, a medical technology company, focuses on developing clinically differentiated solutions in the United States and internationally. It operates through two segments: Prevention and Recovery, and Reconstructive segments.
Health Care · Industrial Specialties · 7,802 employees
CBLL vs ENOV FAQ
Which is bigger, CeriBell or Enovis?
Enovis (ENOV) is larger, with a market capitalization of $1.01B compared with $868.30M for CeriBell (CBLL).
Which stock has performed better over the past year, CBLL or ENOV?
CBLL returned +98.98% over the past 12 months, compared with -41.94% for ENOV (price return, excluding dividends). Past performance does not predict future results.
Are CeriBell and Enovis in the same industry?
Both are in the Health Care sector, but in different industries: Biotechnology: Electromedical & Electrotherapeutic Apparatus for CeriBell and Industrial Specialties for Enovis.